Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.
1919
10
Last FY Revenue $0.1M
Last FY EBITDA -$0.7M
$2.7M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, Double Bond achieved revenue of $0.1M and an EBITDA of -$0.7M.
Double Bond expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Double Bond valuation multiples based on analyst estimatesNTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|
Revenue | XXX | $0.1M | XXX | XXX | XXX |
Gross Profit | XXX | $0.6M | XXX | XXX | XXX |
Gross Margin | XXX | 558% | XXX | XXX | XXX |
EBITDA | XXX | -$0.7M | XXX | XXX | XXX |
EBITDA Margin | XXX | -621% | XXX | XXX | XXX |
EBIT | XXX | -$0.2M | XXX | XXX | XXX |
EBIT Margin | XXX | -149% | XXX | XXX | XXX |
Net Profit | XXX | -$0.7M | XXX | XXX | XXX |
Net Margin | XXX | -653% | XXX | XXX | XXX |
Net Debt | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Double Bond's stock price is SEK 0 (or $0).
Double Bond has current market cap of SEK 30.0M (or $3.1M), and EV of SEK 26.0M (or $2.7M).
See Double Bond trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.7M | $3.1M | XXX | XXX | XXX | XXX | n/a |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Double Bond has market cap of $3.1M and EV of $2.7M.
Double Bond's trades at 23.9x EV/Revenue multiple, and -3.8x EV/EBITDA.
Equity research analysts estimate Double Bond's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Double Bond's P/E ratio is not available.
See valuation multiples for Double Bond and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $3.1M | XXX | $3.1M | XXX | XXX | XXX |
EV (current) | $2.7M | XXX | $2.7M | XXX | XXX | XXX |
EV/Revenue | n/a | XXX | 23.9x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | -3.8x | XXX | XXX | XXX |
EV/EBIT | n/a | XXX | -16.0x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | n/a | XXX | -4.2x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -4.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialDouble Bond's revenue per employee in the last FY averaged $11K, while opex per employee averaged $0.1M for the same period.
Double Bond's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Double Bond's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Double Bond and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | -621% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $11K | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 707% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Benevolent AI | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Double Bond acquired XXX companies to date.
Last acquisition by Double Bond was XXXXXXXX, XXXXX XXXXX XXXXXX . Double Bond acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Double Bond founded? | Double Bond was founded in 1919. |
Where is Double Bond headquartered? | Double Bond is headquartered in Sweden. |
How many employees does Double Bond have? | As of today, Double Bond has 10 employees. |
Is Double Bond publicy listed? | Yes, Double Bond is a public company listed on SAT. |
What is the stock symbol of Double Bond? | Double Bond trades under DBP B ticker. |
When did Double Bond go public? | Double Bond went public in 2015. |
Who are competitors of Double Bond? | Similar companies to Double Bond include e.g. Julphar, Benevolent AI, Galapagos, Pharming. |
What is the current market cap of Double Bond? | Double Bond's current market cap is $3.1M |
Is Double Bond profitable? | Yes, Double Bond is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.